Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03010319 · ClinicalTrials.gov registry record · NA

PriMatrix for the Management of Diabetic Foot Ulcers

A NA study, sponsored by Integra LifeSciences Corporation.

Completed
Registry status
NA
Development phase
226
Enrollment target

NCT03010319: Completed NA study, sponsored by Integra LifeSciences Corporation.

NCT03010319 is a NA study that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 226 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03010319, a NA study, has completed, sponsored by Integra LifeSciences Corporation.

COMPLETED
Registry status
NA
Development phase
226 participants
Enrollment target

Study Summary

The study will evaluate the efficacy of PriMatrix Dermal Repair Scaffold in the management of diabetic foot ulcers in subjects with diabetes mellitus versus the Standard of Care treatment. Half of patients will be treated using PriMatrix while the other half will receive Standard of Care treatment.

Primary Outcome

Complete wound closure was defined as 100% re-epithelialization of the ulcer surface without detectable exudate, confirmed on 2 consecutive study visits 1 week apart.

Interventions

  • DEVICE PriMatrix Dermal Repair Scaffold
  • DEVICE Secondary Dressings
  • DEVICE Offloading device

Trial Details

FieldValue
Enrollment Target 226 participants
Start Date 2017-01
Est. Completion 2020-08
Phase NA
Integra LifeSciences Corporation

60 total trials

What the finished NCT03010319 record still lists

NCT03010319 is an interventional study that assigns participants to a tested intervention. The registered 226 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 3 interventions - of which PriMatrix Dermal Repair Scaffold is the first listed.

NCT03010319 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03010319 about?

NCT03010319 is a clinical study titled "PriMatrix for the Management of Diabetic Foot Ulcers". The study will evaluate the efficacy of PriMatrix Dermal Repair Scaffold in the management of diabetic foot ulcers in subjects with diabetes mellitus versus the Standard of Care treatment. Half of patients will be treated using PriMatrix while the other half will receive Standard of Care treatment.

What is the current status of trial NCT03010319?

This trial is currently completed. It is a NA study. The enrollment target is 226 participants. The study started on 2017-01. Estimated completion is 2020-08.

What interventions are being tested in trial NCT03010319?

The interventions under investigation include: PriMatrix Dermal Repair Scaffold (DEVICE), Secondary Dressings (DEVICE), Offloading device (DEVICE).

Who is sponsoring clinical trial NCT03010319?

This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03010319's enrollment target sits among peer trials

226 471st of 2000 higher than 1,529 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04419272 · 226 participants · Phase 4

    Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

  • NCT05449002 · 226 participants · NA

    Digital Single Session Intervention for Youth Mental Health

  • NCT05488054 · 226 participants · NA

    Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery

  • NCT05924477 · 226 participants · NA

    Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03010319, the US trial registry maintained by the National Library of Medicine. NCT03010319 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.